Detecting familial hypercholesterolaemia in general practice

Australian Family Physician

Volumn 41, Issue 12, 2012, Pages 965-968

  Kirke, Andrew ^a   Watts, Gerald F ^b   Emery, Jon ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Genetics; Heart diseases; Lipid metabolism disorders; Mass screening; Preventive medicine

Indexed keywords

ARTICLE; AUSTRALIA; FAMILIAL HYPERCHOLESTEROLEMIA; GENERAL PRACTICE; HUMAN; MASS SCREENING; METHODOLOGY; PATIENT REFERRAL;

AUSTRALIA; GENERAL PRACTICE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MASS SCREENING; REFERRAL AND CONSULTATION;

EID: 84871117395     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Watts G, Sullivan D, Poplawski N, et al. Familial hypercholesterolaemia: a model of care for Australasia. Atherosclerosis 2011;12(Suppl 2):221-31.
2. The National Collaborating Centre for Primary Care. Identification and management of familial hypercholesterolaemia [database on the Internet], 2008. Available at www.nice.org.uk/nicemedia/pdf/CG071NICEGuideline.pdf.
3. Descamps O, Tenoutasse S, Stephenne X, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 2011;218:272-80.
4. Austin M, Hutter C, Zimmern R, Humphries S. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004;160:407-20.
5. Hamilton-Craig I. Case-finding for familial hypercholesterolemia in the Asia-Pacific region. Semin Vasc Med 2004;4:87-92.
6. Pijlman A, Huijgen R, Verhagen S, et al. Evaluation of cholesterol lowering treatmentof patients with familial hypercholesterolaemia. A large cross-sectional studt in the Netherlands. Atherosclerosis 2010;209:189-94.
7. Gray J, Jaiyeola A, Whiting M, Modell M, Wierzbicki AS. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008;94:754-8.
8. Neil HA, Hammond T, Huxley R, Matthews D, Humphries SE. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ 2000;321:148.
9. Bates T, Burnett JR, Van Bockxmeer FM, Hamilton S, Arnolda L, Watts GF. Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology. Heart Lung Circ 2008;17:411-3.
10. Goldberg AC, Robinson JG, Cromwell WC, Ross JL, Ziajka PE. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011;5(3 Suppl):S46-51.
11. Wilson J, Jungner G. Principles and practice of screening for disease. WHO chronicle. Public Health Papers, #34 p.1-163. Geneva: WHO, 1968.
12. Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HAW. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002;324:1303.
13. Melbourne Institue of Applied Economic and Social Research. Living in Australia HILDA 20122012. Available at www.livinginaustralia.org/results/lifestyle.html.
14. The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice (7th edn). South Melbourne: The RACGP, 2009.
15. Gray J, Jaiyeola A, Whiting M, Modell M, Wierzbicki AS. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008;94:754-8.
16. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Summary report. Pediatrics 2011;128(Suppl 5):S213-56.
17. Familial hypercholesterolaemia. Report of a second WHO Consultation. Geneva, 4 September 1998. Geneva: WHO, 1999.
18. Starr B, Hadfield G, Hutton BA, et al. Development of sensitive and specific age-and gender-specific lowdensity lipoprotein cholesterol cutoffs for diagnosis of first degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med 2008;46:791-803.
19. National Heart, Lung, and Blood Institute. Integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. Available at www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm [Accessed 28 September 2012].